Jesús Gil

30PUBLICATIONS
310CO-AUTHORS
Molecular targetsPredictive and prognostic markersPacific Peoples and disabilityCancer therapy (excl. chemotherapy and radiation therapy)Evolution of developmental systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Apr 24, 2026
Electrophilic compound screening identifies GPX4-dependent ferroptosis as a senescence vulnerability.

|Apr 15, 2026
Spliceosome induction is a druggable dependency of RAS-driven senescence and cancer.

|Jan 15, 2025
SMARCA4 regulates the NK-mediated killing of senescent cells.

Virinder Reen, Mariantonietta D'Ambrosio, Pia Pernille Søgaard

|Nov 15, 2024
Senescence as a therapeutic target in cancer and age-related diseases.

Domhnall McHugh, Imanol Durán, Jesús Gil

|Sep 16, 2024
Defining an Ageing-Related Pathology, Disease or Syndrome: International Consensus Statement.

Emma Short, Ian M Adcock, Bilal Al-Sarireh

|Aug 29, 2024
Ribosomal S6 kinase 1 regulates inflammaging via the senescence secretome.

Suchira Gallage, Elaine E Irvine, Jose Efren Barragan Avila

Pageof 5

Frequent Collaborators

6 joint publications

Bin Sun

5 joint publications

Dominic J Withers

5 joint publications

Santiago Vernia

4 joint publications

Sanjay Khadayate